CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Receives Average Rating of “Hold” from Analysts

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has received an average recommendation of “Hold” from the six brokerages that are currently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $117.00.

CHEOY has been the subject of a number of research analyst reports. Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. UBS Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Finally, Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target for the company. in a research note on Thursday, July 16th.

CochLear Price Performance

CHEOY opened at $46.83 on Friday. The firm has a 50 day moving average price of $41.42 and a 200-day moving average price of $52.30. CochLear has a twelve month low of $31.82 and a twelve month high of $104.65.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.